Nitric oxide mediates mecamylamine- and naloxone-precipitated nicotine withdrawal
- 1 March 1998
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 345 (2) , R1-R2
- https://doi.org/10.1016/s0014-2999(98)00089-2
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Pharmacology of Nicotine: Addiction and TherapeuticsAnnual Review of Pharmacology and Toxicology, 1996
- Nitric Oxide Synthase Inhibitors Preclinical Studies of Potential Use for Treatment of Opioid WithdrawalNeuropsychopharmacology, 1995
- The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the ratPsychopharmacology, 1994
- Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl esterLife Sciences, 1993
- Rodent model of nicotine abstinence syndromePharmacology Biochemistry and Behavior, 1992
- Evidence that nitric oxide modulates food intake in miceLife Sciences, 1991